Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Will the Tumor Models Market Evolve in Terms of Growth and Size by 2029?
The size of the tumor model market has experienced swift expansion in recent years. The market, which was valued at $1.92 billion in 2024, is projected to increase to $2.13 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.3%. This growth during the historic period is driven by factors such as the rise in cancer cases, increased demand for tailor-made medicine, the need for improved preclinical predictability, the growing utilisation of patient-derived xenograft models, and a greater dependence on in vivo efficacy data.
In the coming years, the tumor model market is anticipated to witness a quick expansion. By 2029, it’s predicted to reach a value of $3.23 billion, with a compound annual growth rate (CAGR) of 10.9%. Factors contributing to this growth during the forecast period include the increasing emphasis on models relevant to humans, heightened demand for precision oncology, the emergence of immuno-oncology, and the rising need for high-throughput screening models. There is also a growing interest in rare cancer models. Significant trends projected during this period involve advancements such as three-dimensional (3D) cell culture models, progress in pharmaceutical research, improvements in cell-culture technology, the incorporation of artificial intelligence in cancer modelling, and the introduction of patient-derived organoids.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp
What factors are expected to fuel Tumor Models market growth in the coming years?
The tumor models market is projected to expand due to the increasing demand for personalized medicine. Personalized medicine is characterized by tailor-made healthcare and treatments, taking into account the individual’s genes and lifestyle. This personalized approach is on the rise as people are inclined towards health technologies offering real-time monitoring and bespoke treatment plans suiting their distinct biology. Tumor models contribute to personalized medicine by providing a platform for researchers and clinicians to determine how a person’s tumor will respond to certain treatments. These models replicate the characteristics of real human cancers, facilitating a more patient-specific therapeutic approach. In line with this, the Personalized Medicine Coalition, a professional membership organization based in the US, reported in February 2023 that in 2022, 12 new personalized medicines, making up around 34% of all newly approved therapies, were given the green light. This signifies a significant hike from preceding years. Consequently, the escalating demand for personalized medicine is stimulating the growth of the tumor models market.
What Are The Key Findings From The Segmentation Analysis Of The Tumor Models Market?
The tumor models market covered in this report is segmented
1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models
2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies
3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations
Subsegments:
1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models
2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models
3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models
4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models
Which Trends Are Expected To Shape The Future Of The Tumor Models Market?
Prominent businesses in the tumor models market are concentrating their efforts towards innovating advanced solutions like tumor spheroid models, to increase the physiological relevancy and predictive precision of in vitro cancer models. Tumor spheroid models are essentially three-dimensional (3D) accumulations of cancer cells that naturally form spherical structures in culture. For example, in June 2024, Predictive Oncology, a firm based in the US that provides high-end 3D cell culture technologies and predictive oncology solutions, introduced a new 3D cell technology to speed up the discovery of therapeutic treatments for cancer. The technology presents unique features such as cutting-edge 3D tumor spheroid and organoid models that accurately replicate the tumor microenvironment, along with rapid drug testing via high-throughput screening functions. It also facilitates the creation of personalized tumor models derived from patients, performs detailed assessment of drug penetration in 3D structures, and incorporates AI-powered data analytics for improving predictive accuracy and gaining more profound understanding of therapeutic responses.
What Are The Most Active Companies In The Tumor Models Market Today?
Major companies operating in the tumor models market are Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report
Which Regional Markets Are Attracting The Most Investment In Tumor Models?
North America was the largest region in the tumor models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27441&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model